Biotech
-
NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 – Has Sufficient Cash, Coronavirus Drug Candidate Safe in GLP Safety Toxicology Moving Towards IND
SHELTON, CONNECTICUT – February 16, 2021 — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a global leader in the development of…
Read More » -
Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.’s President, Dr. Anil Diwan
Shelton, CT – January 27, 2021 — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a global leader in the development of…
Read More » -
Applied UV, Inc. to Patent a System to Neutralize Pathogens on Physical Surfaces
Hot off the press! AppliedUV, Inc, (NasdaqCM:AUVI) issues a press release today to announce their pending patent for sanitizing commonly…
Read More » -
Lifequest Signs MOU with Purecycle Inovatif to Establish a Joint Venture in Turkey
Lifequest Subsidiary Biopipe Global Signs Memorandum of Understanding with Purecycle Inovatif to Establish a Joint Venture to Market 100% Sludge…
Read More » -
Applied UV, Inc. Subsidiary, SteriLumen, Inc., Announces Receipt of Purchase Order for Airocide™ Air Quality-Improvement™ System from Dubai Creek Golf & Yacht Club Resort
Mount Vernon, NY, September 22, 2020 – Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), an infection prevention…
Read More » -
Applied UV, Inc. Subsidiary, SteriLumen, Inc. Installs First Ultraviolet Light Disinfecting Devices at Mt. Sinai St. Luke’s Hospital as Part of Evaluation Study
Mount Vernon, NY, September 17, 2020 – Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), an infection prevention…
Read More » -
Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides’ SARS-CoV-2 Therapeutics Program
Shelton, Connecticut — July 8, 2020 — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly…
Read More » -
Pressure Bio: The $3.5 Million Order For Hand Sanitizers Could Really Increase The Momentum Of This Stock
Pressure Bio (OTCPK:PBIO) is one of the most promising microcaps that has been covered by us over the past few…
Read More » -
$3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a Pending Accretive Acquisition of Pressure BioSciences, Into the Multi-Billion Dollar Hand Sanitizer Market
SkinScience Labs, Creator of Award-Winning Dr. Denese Skin Care & Anti-Aging Product Lines, Enters Hand Sanitizer Market with Proprietary Formula…
Read More » -
NanoViricides: Drug Candidates Show Fantastic Results In Animal Model
In our earlier pieces, we have provided an in-depth coverage of the promising biopharma smallcap NanoViricides Inc. (NYSE American: NNVC)…
Read More »